BMI1 and ovarian carcinoma: Similar observations have been made in ovarian cancer, in which the synthetic glucocorticoid dexamethasone induced ROR1 expression, which correlated with elevated RHOA, YAP/TAZ, and BMI-1 levels in a panel of ovarian cancer cell lines as well as in the primary patient-derived cells [167].